Cargando…
Fragment-Based Identification of Influenza Endonuclease Inhibitors
[Image: see text] The influenza virus is responsible for millions of cases of severe illness annually. Yearly variance in the effectiveness of vaccination, coupled with emerging drug resistance, necessitates the development of new drugs to treat influenza infections. One attractive target is the RNA...
Autores principales: | Credille, Cy V., Chen, Yao, Cohen, Seth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948595/ https://www.ncbi.nlm.nih.gov/pubmed/27291165 http://dx.doi.org/10.1021/acs.jmedchem.6b00628 |
Ejemplares similares
-
Correction to Fragment-Based
Identification of Influenza Endonuclease Inhibitors
por: Credille, Cy V., et al.
Publicado: (2017) -
Carboxylic
Acid Isostere Derivatives of Hydroxypyridinones
as Core Scaffolds for Influenza Endonuclease Inhibitors
por: Stokes, Ryjul W., et al.
Publicado: (2022) -
Effects of Lyse-It on endonuclease fragmentation, function and activity
por: Santaus, Tonya M., et al.
Publicado: (2019) -
Identification of Influenza PA(N) Endonuclease Inhibitors via 3D-QSAR Modeling and Docking-Based Virtual Screening
por: Zhang, Chao, et al.
Publicado: (2021) -
Drug Repurposing for Influenza Virus Polymerase Acidic (PA) Endonuclease Inhibitor
por: Meng, Xin, et al.
Publicado: (2021)